| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 16.459 | 23.270 | 34.951 | 42.033 | 46.587 | 51.579 | 54.710 | 66.697 | 64.244 |
| Total Income - EUR | 0 | 16.461 | 23.273 | 46.034 | 42.797 | 46.649 | 51.626 | 55.221 | 67.553 | 64.838 |
| Total Expenses - EUR | 2 | 14.887 | 15.239 | 23.568 | 22.927 | 24.625 | 23.060 | 33.037 | 34.989 | 35.207 |
| Gross Profit/Loss - EUR | -2 | 1.574 | 8.034 | 22.466 | 19.870 | 22.025 | 28.566 | 22.183 | 32.563 | 29.631 |
| Net Profit/Loss - EUR | -2 | 1.081 | 7.391 | 22.006 | 19.444 | 21.580 | 28.060 | 21.647 | 31.905 | 27.725 |
| Employees | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Anarad Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 125 | 11.892 | 8.373 | 30.069 | 25.266 | 19.255 | 12.243 | 6.860 | 3.133 | 2.818 |
| Current Assets | 53 | 6.419 | 10.997 | 22.807 | 16.195 | 18.490 | 26.415 | 24.113 | 30.908 | 27.223 |
| Inventories | 0 | 0 | 885 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 1.395 | 8.050 | 15.987 | 11.771 | 8.460 | 12.985 | 3.419 | 4.017 | 6.105 |
| Cash | 53 | 5.024 | 2.063 | 6.820 | 4.424 | 10.030 | 13.431 | 20.694 | 26.892 | 21.118 |
| Shareholders Funds | 43 | 1.123 | 8.495 | 25.617 | 19.494 | 21.630 | 28.109 | 21.695 | 31.953 | 27.774 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 135 | 17.188 | 10.875 | 27.258 | 21.967 | 16.115 | 10.550 | 9.277 | 3.199 | 2.837 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anarad Med Srl